2 ASX shares that could help set you up for life

Analysts are saying good things about these buy-rated shares.

| More on:
Smiling young parents with their daughter dream of success.

Images source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

When it comes to investing, I'm a big advocate of being patient and buying the crème de la crème of ASX shares when opportunities arise and then holding on for the long-term.

This is instead of building a portfolio filled with so-so companies just because they were looking cheap at the time.

Warren Buffett has previously highlighted his success with this approach. In fact, over an investment period of almost 60 years, Buffett suggested that there are approximately 12 great investment decisions that are responsible for his success. He said:

Our satisfactory results have been the product of about a dozen truly good decisions – that would be about one every five years – and a sometimes-forgotten advantage that favors long-term investors such as Berkshire.

Given how Buffett has delivered an average annual return almost double what the market has achieved since 1965, it's fair to say that he knows what he's talking about.

ASX shares to buy and hold

The good news for investors is there are a couple of high-quality ASX shares that analysts believe are trading at very attractive prices today.

The first is biotechnology company CSL Ltd (ASX: CSL), which is the name behind the CSL Behring, Seqirus, and CSL Vifor businesses.

CSL Behring is a global biotherapeutics leader focused on using the latest technologies to discover, develop, and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas.

Whereas Seqirus is a global leader in influenza protection and CSL Vifor is a global leader in iron deficiency and iron deficiency anaemia therapies.

The team at UBS is very positive on the company's outlook and has a buy rating and $330.00 price target on its shares. It believes the company could deliver double-digit earnings growth over the medium term.

Another ASX share that analysts rate extremely highly is ResMed Inc. (ASX: RMD). It is the world's leading sleep disorder treatment company with a collection of highly regarded medical devices and software solutions.

Due to concerns over the threat of weight loss drugs, its shares are down meaningfully from their highs. Morgans doesn't believe these drugs are a threat and sees the weakness as a buying opportunity.

It has an add rating and $32.82 price target on its shares. It notes that the "company remains well placed and uniquely positioned as it builds a patient-centric, connected-care digital platform that addresses the main pinch points across the healthcare value chain."

Motley Fool contributor James Mickleboro has positions in CSL and ResMed. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Berkshire Hathaway, CSL, and ResMed. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool Australia has recommended Berkshire Hathaway and CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on How to invest

A young woman's hands are shown close up with many blingy gold rings on her fingers and two large gold chains around her neck with dollar signs on them.
How to invest

Got $5,000? 5 ASX shares to buy for lasting wealth

Analysts think these shares are top options to buy and hold.

Read more »

A young well-dressed couple at a luxury resort celebrate successful life choices.
How to invest

With no savings at 40, I'd use Warren Buffett's golden rule to build wealth with ASX shares

It's never too late to start investing for a golden retirement.

Read more »

A couple sits in their lounge room with a large piggy bank on the coffee table. They smile while the male partner feeds some money into the slot while the female partner looks on with an iPad style device in her hands as though they are budgeting.
How to invest

Where to invest $8,000 in April 2024

Here's what sort of returns could be on offer from these ASX shares according to analysts.

Read more »

An ASX dividend investor lies back in a deck chair with his hands behind his head on a quiet and beautiful beach with blue sky and water in the background.
How to invest

Shares vs. property: How to generate $500 passive income per month

We run the numbers.

Read more »

A woman holds a lightbulb in one hand and a wad of cash in the other
How to invest

ASX 200 shares vs term deposits: What $5,000 invested a year ago is worth now

Which has been the superior option for investors?

Read more »

Kid on a skateboard with cardboard wings soars along the road.
How to invest

Shares vs. property: Why cheaper homes and ASX small-cap shares are rising fastest in 2024

We look into the changing trends in shares vs. property.

Read more »

a man wearing casual clothes fans a selection of Australian banknotes over his chin with an excited, widemouthed expression on his face.
How to invest

$20,000 invested in these ASX 200 shares 10 years ago is worth how much?

Would you be laughing all the way to the bank today or not?

Read more »

Busy freeway and tollway at dusk
How to invest

If inflation rebounds I'll be buying this leading ASX 200 share

Inflation doesn’t impact all ASX 200 shares equally.

Read more »